tweenvest

Double Bond Pharmaceutical International AB (publ) (XSAT: DBP B)

Health Care · Pharmaceuticals · SE

Skr0.11

-0.44% today · +2.8% 1Y

Public summary
A free snapshot of Double Bond Pharmaceutical International AB (publ), with figures as of Nov 15, 2026. The full analysis is in the app.Open in the app

Double Bond Pharmaceutical International AB (publ) (XSAT: DBP B) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $2.51M.

Over the last twelve months the share price has gained 2.8%, trading between 0.10 and 0.27.

Tweenvest scores Double Bond Pharmaceutical International AB (publ) across four factors: quality 36/100, value 30/100, growth 49/100. Its strongest factor is growth.

DBP B price history

Nov 21, 2025 · 0.11Weekly closes 0.11 – 0.19Sep 30, 2026 · 0.11

Key figures

Market cap
$2.51M
Revenue (TTM)
$28.29K
P/E
74.72
EPS
0.00
Dividend yield
—
Beta (5Y)
0.81
52-week high
Skr0.27
52-week low
Skr0.10
Avg volume (3M)
—
Shares outstanding
223.85M
Employees
—
Next earnings
—
CompanyMarket capPriceDay
Herbal Dispatch Inc.CNSX: HERB$2.75MCA$0.030.00%
1933 Industries Inc.CNSX: TGIF$2.74MCA$0.01-25.00%
Bacil Pharma LimitedBSE: 524516$2.56MRs16.80-1.12%
Q/C Technologies, Inc.NasdaqCM: QCLS$2.53M$0.31-8.88%
Welcure Drugs and Pharmaceuticals LimitedBSE: 524661$2.49MRs0.190.00%
Invion LimitedASX: IVX$2.47MAU$0.03-10.81%
Simply Solventless Concentrates Ltd.TSXV: HASH$2.42MCA$0.03-25.00%
Grey Matters Health Inc.CNSX: GREY$2.42MCA$0.31-12.86%

Browse every Pharmaceuticals company →